Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Neutral
Debt to Equity Rating
Strong Buy
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Simple Moving Average
Strong Sell
Exponential Moving Average
Strong Sell
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Elanco Animal Health Incorporated Common Stock (ELAN)
Pharmaceutical Preparations
Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
2500 INNOVATION WAY
GREENFIELD, IN
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
09/20/2018
Market Cap
7,219,913,220
Shares Outstanding
492,800,000
Weighted SO
492,798,113
Total Employees
N/A
Upcoming Earnings
08/05/2024
Beta
1.4240
Last Div
0.0000
Range
8.52-18.8
Chg
0.0256
Avg Vol
5501651
Mkt Cap
7219913220
Exch
NYSE
Country
US
Phone
877 352 6261
DCF Diff
22.6510
DCF
-8.0710
Div Yield
0.0000
P/S
1.6073
EV Multiple
14.0698
P/FV
1.2148
Div Yield %
0.0000
P/E
-5.7515
PEG
-0.5129
Payout
0.0000
Current Ratio
2.9277
Quick Ratio
1.7518
Cash Ratio
0.3036
DSO
87.7560
DIO
274.2607
Op Cycle
362.0167
DPO
49.5406
CCC
312.4762
Gross Margin
0.5227
Op Margin
0.0592
Pretax Margin
-0.2769
Net Margin
-0.2794
Eff Tax Rate
-0.0088
ROA
-0.0912
ROE
-0.2061
ROCE
0.0215
NI/EBT
1.0088
EBT/EBIT
-4.6767
EBIT/Rev
0.0592
Debt Ratio
0.4124
D/E
0.9552
LT Debt/Cap
0.4790
Total Debt/Cap
0.4886
Int Coverage
0.9852
CF/Debt
0.0981
Equity Multi
2.3164
Rec Turnover
4.1593
Pay Turnover
7.3677
Inv Turnover
1.3309
FA Turnover
4.7334
Asset Turnover
0.3264
OCF/Share
1.1271
FCF/Share
0.8600
Cash/Share
0.8418
OCF/Sales
0.1240
FCF/OCF
0.7630
CF Coverage
0.0981
ST Coverage
2.6150
CapEx Coverage
4.2197
Div&CapEx Cov
4.2197
P/BV
1.2148
P/B
1.2148
P/S
1.6073
P/E
-5.7515
P/FCF
16.9880
P/OCF
12.9589
P/CF
12.9589
PEG
-0.5129
P/S
1.6073
EV Multiple
14.0698
P/FV
1.2148
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
19.30K Shares Bought (99.99 %)
0.00 Shares Sold (0.01%)
3 - 6 Months
1.58M Shares Bought (84.19 %)
297.65K Shares Sold (15.81%)
6 - 9 Months
86.45K Shares Bought (98.82 %)
1.03K Shares Sold (1.18%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 799.30M | ▼ 787.00M | ▲ 1.14B | ▼ 1.11B | ▼ 988.00M | ▲ 1.04B | ▲ 1.21B |
Cost Of Revenue | 412.50M | ▼ 410.10M | ▲ 596.20M | ▼ 512.00M | ▼ 448.00M | ▲ 516.00M | ▼ 515.00M |
Gross Profit | 386.80M | ▼ 376.90M | ▲ 543.50M | ▲ 601.00M | ▼ 540.00M | ▼ 519.00M | ▲ 690.00M |
Gross Profit Ratio | 0.48 | ▼ 0.48 | ▼ 0.48 | ▲ 0.54 | ▲ 0.55 | ▼ 0.50 | ▲ 0.57 |
Research And Development Expenses | 61.10M | ▲ 67.30M | ▲ 112.70M | ▼ 92.00M | ▼ 80.00M | ▼ 79.00M | ▲ 87.00M |
General And Administrative Expenses | 185.10M | ▲ 185.90M | ▼ 182.00M | ▼ 0.00 | ▲ 102.00M | ▼ 85.00M | ▼ 0.00 |
Selling And Marketing Expenses | 0.00 | 0.00 | ▲ 611.00M | ▼ 0.00 | ▲ 201.00M | ▲ 207.00M | ▼ 0.00 |
Selling General And Administrative Expenses | 185.10M | ▲ 185.90M | ▲ 374.10M | ▼ 329.00M | ▼ 303.00M | ▼ 292.00M | ▲ 337.00M |
Other Expenses | -25.70M | ▲ -6.30M | ▲ 16.60M | ▼ 3.00M | ▲ 130.00M | ▼ -34.00M | ▲ -9.00M |
Operating Expenses | 296.30M | ▲ 304.60M | ▲ 650.50M | ▼ 560.00M | ▼ 513.00M | ▼ 509.00M | ▲ 557.00M |
Cost And Expenses | 708.80M | ▲ 714.70M | ▲ 1.25B | ▼ 1.07B | ▼ 961.00M | ▲ 1.03B | ▲ 1.07B |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 62.00M | ▼ -210.00M | ▲ 0.00 |
Interest Expense | 29.60M | ▼ 18.70M | ▲ 60.40M | ▼ 55.00M | ▲ 62.00M | ▲ 67.00M | ▼ 66.00M |
Depreciation And Amortization | 50.10M | ▲ 51.40M | ▲ 163.70M | ▼ 139.00M | ▼ 130.00M | ▲ 171.00M | ▼ 166.00M |
Ebitda | 186.60M | ▼ 117.40M | ▼ 73.30M | ▲ 183.00M | ▼ 136.00M | ▲ 147.00M | ▲ 290.00M |
Ebitda Ratio | 0.23 | ▼ 0.15 | ▼ 0.06 | ▲ 0.16 | ▼ 0.14 | ▲ 0.14 | ▲ 0.24 |
Operating Income | 90.50M | ▼ 72.30M | ▼ -107.00M | ▲ -66.00M | ▲ 6.00M | ▼ -24.00M | ▲ 133.00M |
Operating Income Ratio | 0.11 | ▼ 0.09 | ▼ -0.09 | ▲ -0.06 | ▲ 0.01 | ▼ -0.02 | ▲ 0.11 |
Total Other Income Expenses Net | -71.70M | ▲ -57.90M | ▼ -150.70M | ▲ -107.00M | ▲ -94.00M | ▲ -70.00M | ▲ -55.00M |
Income Before Tax | -2.20M | ▼ -4.30M | ▼ -318.10M | ▲ -121.00M | ▲ -88.00M | ▼ -127.00M | ▲ 12.00M |
Income Before Tax Ratio | -0.00 | ▼ -0.01 | ▼ -0.28 | ▲ -0.11 | ▲ -0.09 | ▼ -0.12 | ▲ 0.01 |
Income Tax Expense | -18.60M | ▲ 5.20M | ▼ 4.70M | ▼ -24.00M | ▼ -34.00M | ▲ 14.00M | ▼ -20.00M |
Net Income | 16.40M | ▼ -9.50M | ▼ -322.80M | ▲ -97.00M | ▲ -54.00M | ▼ -141.00M | ▲ 32.00M |
Net Income Ratio | 0.02 | ▼ -0.01 | ▼ -0.28 | ▲ -0.09 | ▲ -0.05 | ▼ -0.14 | ▲ 0.03 |
Eps | 0.04 | ▼ -0.03 | ▼ -0.66 | ▲ -0.20 | ▲ -0.11 | ▼ -0.29 | ▲ 0.06 |
Eps Diluted | 0.04 | ▼ -0.03 | ▼ -0.66 | ▲ -0.20 | ▲ -0.11 | ▼ -0.29 | ▲ 0.06 |
Weighted Average Shs Out | 365.60M | ▲ 373.00M | ▲ 486.20M | ▲ 487.40M | ▲ 488.50M | ▲ 492.80M | ▲ 493.20M |
Weighted Average Shs Out Dil | 365.60M | ▲ 374.80M | ▲ 486.20M | ▲ 487.40M | ▲ 488.50M | ▲ 492.80M | ▲ 496.00M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 474.80M | ▼ 334.00M | ▲ 494.70M | ▲ 638.00M | ▼ 345.00M | ▲ 352.00M | ▼ 345.00M |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 14.00M | ▼ 0.00 | 0.00 |
Cash And Short Term Investments | 474.80M | ▼ 334.00M | ▲ 494.70M | ▲ 638.00M | ▼ 345.00M | ▲ 352.00M | ▼ 345.00M |
Net Receivables | 709.40M | ▲ 889.90M | ▲ 1.08B | ▼ 1.03B | ▼ 1.00B | ▲ 1.01B | ▲ 1.08B |
Inventory | 1.00B | ▲ 1.05B | ▲ 1.58B | ▼ 1.37B | ▲ 1.54B | ▲ 1.74B | ▼ 1.64B |
Other Current Assets | 113.90M | ▼ 87.40M | ▲ 256.30M | ▼ 237.00M | ▲ 394.00M | ▼ 310.00M | ▲ 338.00M |
Total Current Assets | 2.50B | ▼ 2.37B | ▲ 3.42B | ▼ 3.28B | ▲ 3.28B | ▲ 3.41B | ▲ 4.05B |
Property Plant Equipment Net | 922.40M | ▲ 955.30M | ▲ 1.32B | ▼ 1.06B | ▼ 999.00M | ▲ 1.03B | ▼ 949.00M |
Goodwill | 2.96B | ▲ 2.99B | ▲ 6.22B | ▼ 6.17B | ▼ 5.99B | ▼ 5.09B | ▼ 4.48B |
Intangible Assets | 2.45B | ▲ 2.48B | ▲ 6.39B | ▼ 5.59B | ▼ 4.84B | ▼ 4.49B | ▼ 4.20B |
Goodwill And Intangible Assets | 5.41B | ▲ 5.47B | ▲ 12.61B | ▼ 11.76B | ▼ 10.84B | ▼ 9.59B | ▼ 8.67B |
Long Term Investments | 15.30M | ▼ 0.00 | 0.00 | 0.00 | ▲ 37.00M | ▼ 26.00M | ▼ 25.00M |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -37.00M | ▲ -26.00M | ▲ -25.00M |
Other Non Current Assets | 103.10M | ▲ 185.00M | ▲ 347.80M | ▲ 387.00M | ▼ 378.00M | ▼ 341.00M | ▲ 346.00M |
Total Non Current Assets | 6.45B | ▲ 6.61B | ▲ 14.28B | ▼ 13.21B | ▼ 12.21B | ▼ 10.96B | ▼ 9.97B |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 8.96B | ▲ 8.99B | ▲ 17.69B | ▼ 16.48B | ▼ 15.49B | ▼ 14.36B | ▼ 14.02B |
Account Payables | 205.20M | ▲ 222.60M | ▲ 501.00M | ▼ 418.00M | ▼ 390.00M | ▼ 270.00M | ▲ 302.00M |
Short Term Debt | 29.00M | ▼ 24.50M | ▲ 554.50M | ▼ 294.00M | ▲ 388.00M | ▼ 38.00M | 38.00M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 367.60M | ▼ 116.00M | ▲ 148.60M | ▲ 185.00M | ▼ 0.00 | ▲ 524.00M | ▼ 318.00M |
Other Current Liabilities | 368.90M | ▲ 455.40M | ▲ 872.20M | ▼ 746.00M | ▲ 924.00M | ▼ 409.00M | ▲ 574.00M |
Total Current Liabilities | 970.70M | ▼ 818.50M | ▲ 2.08B | ▼ 1.64B | ▲ 1.70B | ▼ 1.24B | ▼ 1.23B |
Long Term Debt | 2.44B | ▼ 2.33B | ▲ 5.57B | ▲ 6.03B | ▼ 5.45B | ▲ 5.74B | ▼ 5.73B |
Deferred Revenue Non Current | 109.10M | ▼ 82.50M | ▲ 345.70M | ▼ 271.00M | ▼ 0.00 | ▲ 184.00M | ▼ 0.00 |
Deferred Tax Liabilities Non Current | 114.60M | ▼ 100.80M | ▲ 900.30M | ▼ 745.00M | ▼ 662.00M | ▼ 567.00M | ▼ 530.00M |
Other Non Current Liabilities | 121.50M | ▼ 106.60M | ▲ 322.10M | ▼ 261.00M | ▲ 390.00M | ▲ 411.00M | ▲ 474.00M |
Total Non Current Liabilities | 2.79B | ▼ 2.62B | ▲ 7.14B | ▲ 7.30B | ▼ 6.50B | ▲ 6.90B | ▼ 6.73B |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 111.00M | ▼ 110.00M | ▼ 0.00 |
Total Liabilities | 3.76B | ▼ 3.44B | ▲ 9.22B | ▼ 8.95B | ▼ 8.20B | ▼ 8.14B | ▼ 7.96B |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Retained Earnings | 16.40M | ▲ 84.30M | ▼ -477.20M | ▼ -949.00M | ▼ -1.06B | ▼ -2.29B | ▲ -2.26B |
Accumulated Other Comprehensive Income Loss | -222.20M | ▲ -173.70M | ▲ 303.00M | ▼ -209.00M | ▼ -392.00M | ▲ -266.00M | ▼ -465.00M |
Other Total Stockholders Equity | 5.40B | ▲ 5.64B | ▲ 8.65B | ▲ 8.70B | ▲ 8.74B | ▲ 8.78B | 8.78B |
Total Stockholders Equity | 5.20B | ▲ 5.55B | ▲ 8.48B | ▼ 7.54B | ▼ 7.29B | ▼ 6.22B | ▼ 6.06B |
Total Equity | 5.20B | ▲ 5.55B | ▲ 8.48B | ▼ 7.54B | ▼ 7.29B | ▼ 6.22B | ▼ 6.06B |
Total Liabilities And Stockholders Equity | 8.96B | ▲ 8.99B | ▲ 17.69B | ▼ 16.48B | ▼ 15.49B | ▼ 14.36B | ▼ 14.02B |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 8.96B | ▲ 8.99B | ▲ 17.69B | ▼ 16.48B | ▼ 15.49B | ▼ 14.36B | ▼ 14.02B |
Total Investments | 15.30M | ▼ 0.00 | 0.00 | 0.00 | ▲ 37.00M | ▼ 26.00M | ▼ 25.00M |
Total Debt | 2.47B | ▼ 2.36B | ▲ 6.13B | ▲ 6.32B | ▼ 5.84B | ▼ 5.77B | ▼ 5.77B |
Net Debt | 2.00B | ▲ 2.02B | ▲ 5.63B | ▲ 5.68B | ▼ 5.49B | ▼ 5.42B | ▼ 5.42B |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | 16.40M | ▼ -9.50M | ▼ -322.80M | ▲ -97.00M | ▲ -55.00M | ▼ -141.00M | ▲ 32.00M |
Depreciation And Amortization | 73.70M | ▲ 83.40M | ▲ 222.20M | ▼ 174.00M | ▼ 168.00M | ▲ 171.00M | ▼ 166.00M |
Deferred Income Tax | -73.30M | ▲ -14.80M | ▲ 35.00M | ▼ -35.00M | ▲ -21.00M | ▼ -53.00M | ▲ 0.00 |
Stock Based Compensation | 5.80M | ▲ 12.70M | ▲ 16.60M | ▲ 18.00M | ▼ 15.00M | 15.00M | ▼ 11.00M |
Change In Working Capital | 54.20M | ▼ 39.30M | ▼ -125.20M | ▲ 156.00M | ▼ -78.00M | ▲ 146.00M | ▼ -177.00M |
Accounts Receivables | 48.40M | ▼ -172.40M | ▲ 14.00M | ▼ -25.00M | ▲ 14.00M | ▼ -40.00M | ▲ 0.00 |
Inventory | -39.00M | ▲ -33.10M | ▼ -94.00M | ▲ 27.00M | ▼ -269.00M | ▲ -160.00M | ▲ 0.00 |
Accounts Payables | -8.40M | ▼ -29.20M | ▲ 369.30M | ▼ -120.00M | ▲ -98.00M | ▲ 200.00M | ▼ 0.00 |
Other Working Capital | 53.20M | ▲ 274.00M | ▼ -414.50M | ▲ 274.00M | ▲ 275.00M | ▼ 146.00M | ▼ -177.00M |
Other Non Cash Items | 62.70M | ▼ 15.20M | ▲ 81.30M | ▼ 7.00M | ▼ -16.00M | ▲ 19.00M | ▲ 313.00M |
Net Cash Provided By Operating Activities | 139.50M | ▼ 126.30M | ▼ -92.90M | ▲ 223.00M | ▼ 13.00M | ▲ 157.00M | ▼ 2.00M |
Investments In Property Plant And Equipment | -60.20M | ▼ -111.40M | ▼ -146.90M | ▲ -91.00M | ▲ -79.00M | ▲ -41.00M | ▲ -24.00M |
Acquisitions Net | -882.10M | ▲ -32.80M | ▼ -5.00B | ▲ 0.00 | ▲ 2.00M | ▼ 0.00 | ▼ -5.00M |
Purchases Of Investments | 0.00 | 0.00 | ▲ 5.05B | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 894.20M | ▼ 69.90M | ▼ 29.40M | ▼ 17.00M | ▼ 1.00M | ▲ 6.00M | ▲ 66.00M |
Net Cash Used For Investing Activities | -48.10M | ▼ -74.30M | ▲ -73.30M | ▼ -74.00M | ▼ -76.00M | ▲ -35.00M | ▲ 37.00M |
Debt Repayment | 0.00 | ▼ -6.10M | ▼ -267.30M | ▼ -268.00M | ▲ -70.00M | ▼ -139.00M | ▲ -13.00M |
Common Stock Issued | 0.00 | 0.00 | ▲ 1.22B | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -362.40M | ▲ -100.00K | ▼ -970.00M | ▲ 312.00M | ▼ -14.00M | ▲ 124.00M | ▼ -14.00M |
Net Cash Used Provided By Financing Activities | -362.40M | ▲ -6.20M | ▼ -18.30M | ▲ 44.00M | ▼ -84.00M | ▼ -139.00M | ▲ -27.00M |
Effect Of Forex Changes On Cash | 13.60M | ▼ -21.00M | ▲ 19.30M | ▼ -8.00M | ▲ 32.00M | ▼ 0.00 | ▼ -19.00M |
Net Change In Cash | -257.40M | ▲ 24.80M | ▼ -165.20M | ▲ 185.00M | ▼ -115.00M | ▲ -17.00M | ▲ -7.00M |
Cash At End Of Period | 677.50M | ▼ 345.10M | ▲ 505.40M | ▲ 638.00M | ▼ 345.00M | ▲ 352.00M | ▼ 345.00M |
Cash At Beginning Of Period | 934.90M | ▼ 320.30M | ▲ 670.60M | ▼ 453.00M | ▲ 460.00M | ▼ 369.00M | ▼ 352.00M |
Operating Cash Flow | 139.50M | ▼ 126.30M | ▼ -92.90M | ▲ 223.00M | ▼ 13.00M | ▲ 157.00M | ▼ 2.00M |
Capital Expenditure | -60.20M | ▼ -111.40M | ▼ -146.90M | ▲ -91.00M | ▲ -79.00M | ▲ -41.00M | ▲ -24.00M |
Free Cash Flow | 79.30M | ▼ 14.90M | ▼ -239.80M | ▲ 132.00M | ▼ -66.00M | ▲ 116.00M | ▼ -22.00M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)